Mark Butler has guaranteed he won’t cut people off the NDIS until alternative supports are in place, setting a deadline ticking for the states to get on board.
Falling immunisation rates, fuelled by misinformation, has sparked a national campaign calling on Australians to speak with their doctor about vaccinations.
Ukraine is trying to turn more of the fighting over to unmanned systems as it struggles with troop shortages and seeks ways to defend itself without risking heavy losses of soldiers.
Calluses are thick, rough patches that are ‘your skin’s natural defence’ against chafing and irritation. Here’s what you need to do to get rid of them.
Adam Shand travels to Zimbabwe to take part in a psychedelic drug ritual which Aussie combat veterans are turning to in a last ditch hope to cure drug addictions and ease post traumatic stress.
Canva boasts a $60 billion private valuation and is tipped to seek a share market listing, but is it immune from the brutal sell-off that hit all public software businesses in 2026.
THE NEW YORK TIMES: While data indicated that new Alzheimer’s drugs could modestly slow cognitive decline for some patients, would that effect be meaningful or too slight to make a difference?
The mania for businesses directly linked to demand for AI is set to sweep across the ASX as soon as the June quarter with two potentially large listings.